FDA recently approved changes to the EPIVIR (lamivudine) package insert.
The approved changes are detailed here.
FDA approves changes to the Epivir label
01/10/2017
EATG » FDA approves changes to the Epivir label
Newsletter / News bulletin
Latest news
Is self-testing with the rapid HIV test reliable?
Researchers reviewed previous studies to address concerns regarding the reliability of a self-administered rapid HIV test. HIV self-testing is highly accepted among many groups and is a useful way to…
Read moreAn aspirin a day may keep HIV away, study finds
An affordable, globally available drug – low-dose Aspirin – shows promise as a new approach to preventing HIV transmission, a University of Manitoba study has found. HIV infection rates remain…
Read moreNew antibody analysis accelerates rational vaccine design
Scripps Research study illuminates humoral immune response to experimental vaccines. A team at Scripps Research has come up with a faster way to analyze the outcome of experimental vaccines against…
Read moreLatest projects
EFOEUPATI – Ensuring the future of EUPATI beyond 2020
Project aims: To ensure the sustainability of the results of the EUPATI project, to develop sustainable models of collaboration to ensure this, and put into place the infrastructure required for…
PARADIGM – Patients Active in Research and Dialogues for an Improved Generation of Medicines
Project aims: To provide a framework that allows structured, meaningful, sustainable and ethical patient engagement throughout three key decision-making points of the development of medicinal products: (i) the research priority…
HIV Outcomes – Beyond Viral Suppression
Initiative aims: HIV Outcomes, is a multi-stakeholder initiative developing and communicating expert, evidence based consensus recommendations for policy makers focused on the provision and delivery of high quality of care…
